ESR1 and neoplasm: Knowledge so far on the possible causes for the intrinsic and acquired resistance have been attributed to the pharmacological property of tamoxifen, alterations in the expression and function of ER, interactions of tumors with local microenvironment, and genetic alterations of tumor cells [3]–[6].